Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

First-line gefitinib in advanced non-small-cell lung cancer patients harboring somatic EGFR mutations

Sequist L.V., Martins R.G., Spigel D., Grunberg S.M., Spira A., Jänne P.A., Joshi V.A., McCollum D., Evans T., Muzikansky A., Kuhlman G., Goldberg J.S., Patel J., Malamud S., Settleman J., Iafrate A.J., Engelman J.A., Haber D.A., Johnson B.E., and Lynch T.J. . First-line gefitinib in advanced non-small-cell lung cancer patients harboring somatic EGFR mutations. Journal of Clinical Oncology. 2008.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.